FindTrial
Sign In

Clinical studies on PRP antibody titer after administration with Haemophilus influenzae type b conjudate vaccine.

Clinical studies on PRP antibody titer after administration with Haemophilus influenzae type b conjudate vaccine.

Status
Unknown
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1080223268
Enrollment
Unknown
Registered
2016-07-21
Start date
2016-07-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

investigational material(s) Generic name etc : the Haemophilus influenzae type b conjudate vaccine INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration

Sponsors

The Chemo-Sero-Therapeutic Research Institute
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: More than 2 months old, less than 60 months old

Exclusion criteria

Exclusion criteria:

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026